Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Alderson

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Mutation Research|September 1, 1985
Formaldehyde-induced mutagenesis: a novel mechanism for its actionT Alderson
Anti-Cancer Drugs|December 1, 1991
Poly(ADP-ribosylation) processing as a target for the anti-tumor effects of the cell differentiating agent, hexamethylenebisacetamide, and the N6-substituted adenosinesT Alderson
Medical Education|August 8, 2001
Evaluating primary care as a base for medical education: the report of the Cambridge Community-based Clinical CourseN Oswald, T Alderson, S Jones
Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Tumour localisation by human monoclonal antibodiesK Sikora, T Alderson, A Nethersell, et al.
Mutation Research|June 1, 1976
UV mutagenesis in inhibitor depleted conidia of Aspergillus nidulansB R Scott, T Alderson, D G Papworth
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1983
Detection of lymphocytes in malignant gliomas by monoclonal antibodiesK Yasuda, T Alderson, J Phillips, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1983
Localisation of malignant glioma by a radiolabelled human monoclonal antibodyJ Phillips, T Alderson, K Sikora, et al.
Mutation Research|October 1, 1977
The induction of mutations to 2-thioxanthine resistance in inhibitor depleted conidia of Aspergillus nidulans by gamma-radiation in the presence of oxygen or nitrogenB R Scott, T Alderson, D G Papworth
Chemical Communications (Cambridge, England)|September 21, 2002
Decreased methane formation from the hydrogenation of carbon monoxide using zeolite/cobalt-manganese oxide composite catalystsM Johns, P Landon, T Alderson, et al.
Lancet (London, England)|January 15, 1983
Subcutaneous culture chamber for continuous infusion of monoclonal antibodiesJ V Watson, T Alderson, K Sikora, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Mutation Research|September 1, 1985
Formaldehyde-induced mutagenesis: a novel mechanism for its actionT Alderson
Anti-Cancer Drugs|December 1, 1991
Poly(ADP-ribosylation) processing as a target for the anti-tumor effects of the cell differentiating agent, hexamethylenebisacetamide, and the N6-substituted adenosinesT Alderson
Medical Education|August 8, 2001
Evaluating primary care as a base for medical education: the report of the Cambridge Community-based Clinical CourseN Oswald, T Alderson, S Jones
Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Tumour localisation by human monoclonal antibodiesK Sikora, T Alderson, A Nethersell, et al.
Mutation Research|June 1, 1976
UV mutagenesis in inhibitor depleted conidia of Aspergillus nidulansB R Scott, T Alderson, D G Papworth
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1983
Detection of lymphocytes in malignant gliomas by monoclonal antibodiesK Yasuda, T Alderson, J Phillips, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1983
Localisation of malignant glioma by a radiolabelled human monoclonal antibodyJ Phillips, T Alderson, K Sikora, et al.
Mutation Research|October 1, 1977
The induction of mutations to 2-thioxanthine resistance in inhibitor depleted conidia of Aspergillus nidulans by gamma-radiation in the presence of oxygen or nitrogenB R Scott, T Alderson, D G Papworth
Chemical Communications (Cambridge, England)|September 21, 2002
Decreased methane formation from the hydrogenation of carbon monoxide using zeolite/cobalt-manganese oxide composite catalystsM Johns, P Landon, T Alderson, et al.
Lancet (London, England)|January 15, 1983
Subcutaneous culture chamber for continuous infusion of monoclonal antibodiesJ V Watson, T Alderson, K Sikora, et al.
Pageof 2